Monthly Archives: May 2013

Featured Stories

Smith & Nephew Recalls Metal-on-Metal Hip Implant Component

Medical device maker, Smith & Nephew, just issued a recall for a metal-on-metal hip implant component, a part of one of its all-metal hip replacement systems.

Read More

Canadian Warning Issued for Actos Bladder Cancer Side Effect Risk

Health Canada has become the most recent national drug regulator to issue a warning about Actos and bladder cancer. Last month, the agency warned that interim results from a 10-year-study indicated that patients taking Actos for more than a year faced an increased risk of bladder cancer. Health Canada also ...

Read More

Indiana Woman Alleges Serious Injuries From Transvaginal Mesh Products

Parker Waichman LLP, a national law firm, just filed a lawsuit on behalf of a woman who suffered injuries after receiving transvaginal mesh implants. The lawsuit suit alleges that the transvaginal mesh created an unreasonable risk and directly caused her injuries.

Read More

Toxic Nano-Particles from Failing Metal-on-Metal Hip Replacements May Pose Long-Term Health Risks

According to a new study, failing metal-on-metal hip implants generate toxic nano-particles that release Cobalt 2+ ions, which not only cause inflammation in surrounding tissue, but have the potential to cause long-term damage to the genetic material of cells. According to a report published by Medicalxpress.com, this “genotoxicity” could ...

Read More

FDA Gives 7 Companies Go Ahead To Market Generic Plavix

The U.S. Food & Drug Administration (FDA) just gave seven companies the go-ahead to market generic Plavix. Plavix is a blood thinner prescribed for the prevention of blood clots, heart attacks, and which has been linked to serious side effects such as the heart attacks and strokes it is supposed to ...

Read More

Cancer Groups Call for E-cigarettes Regulation/Research

Two-Leading-Cancer-Groups-Issue-Call-for-Regulation-of-E-cigarettes-and-Research-on-Health-Risks

The American Society of Clinical Oncology & the American Association for Cancer Research called for government regulation & research of e-cigarettes on health effects.

Read More

Oklahoma Woman Latest to Head to Court Over Alleged DePuy ASR Hip Implant Injuries

Lawsuits filed by alleged victims of DePuy Orthopaedics’ recalled ASR hip replacement devices continue to pile up in the multidistrict litigation currently underway in U.S. District Court, Northern District of Ohio. Most recently, a woman from Pryor, Oklahoma, filed suit alleging complications caused by a DePuy ASR hip implant ...

Read More

Tentative Ohio Fracking Regulations Criticized as too Lax

Lawmakers in Ohio have tentatively passed new regulations governing hydraulic fracturing (fracking) drilling but they’ve immediately been criticized for being too favorable to the natural gas and oil industries.

Read More

Federal Judge Certifies Medtronic Infuse Shareholder Class Action Lawsuit

A shareholder lawsuit alleging Medtronic Inc. illegally promoted the off-label use of its Infuse bone growth product has been granted class action status by U.S. District Judge Paul Magnuson of Minnesota. According to a report from Law360.com, the Medtronic Infuse off-label promotion lawsuit was filed by several institutional investors on ...

Read More

Study Finds SSRI Antidepressant Side Effects Outweigh Their Benefits

A new study is raising more concerns about the safety of commonly used antidepressants, including selective serotonin reuptake (SSRI) inhibitor antidepressants. Investigators who conducted the study, which is published in the journal Frontiers in Psychology, posit that increased knowledge of the negative effects of SSRIs and other antidepressants could reduce ...

Read More

Yale’s Infuse® Bone Graft Study Expected in June

Yale_Infuse_Bone_Graft_study

A Yale University report concerning the bone graft product Infuse® is expected out next month. Device maker, Medtronic, commissioned Yale University researchers to conduct independent studies of its Infuse® bone graft products, allegedly in response to a June 2011 report … Continue reading

Posted in Defective Medical Devices, Medtonic Infuse, Medtronic Infuse |

Blood Cancer, Rheumatoid Arthritis Drug, MabThera, Linked to Severe Skin Reactions

Mabthera-Skin-Reactions

Roche Products Limited just issued a letter to healthcare providers in cooperation with the European Medicines Agency (EMA) and the Medicines and Healthcare products Regulatory Agency (MHRA) concerning the use of MabThera (rituximab) and severe skin reactions. According to Roche, … Continue reading

Posted in Health Concerns, Pharmaceuticals |

Januvia, Byetta, Other Diabetes Drugs Focus of Controversy

Januvia_Diabetes

Some popular and money making diabetes drugs are at the center of a conflict over disturbing research findings. Although Dr. Peter C. Butler declined to test its then-new diabetes medication, Januvia, he ultimately relented and, in 2008, observed that the … Continue reading

Posted in Byetta Cancer, Pharmaceuticals |

Supreme Court of New Jersey Centralizes Mirena® IUD Litigation

Mirena_NJ_Supreme_Court

The Supreme Court of New Jersey just reconsidered a prior decision and is centralizing all Mirena® intrauterine device (IUD) litigation in Bergen County, New Jersey. This will enable the process to move more efficiently given that many of the plaintiffs … Continue reading

Posted in Defective Medical Devices, Mirena IUD |

Study: Zyprexa, Other Antipsychotics, Associated with Increased Risks for Torsade de Pointes

Zyprexa_Torsade

A recent study has found that some antipsychotic drugs were associated with increased risks for developing torsade de pointes (TdP), a type of abnormal heart rhythm, and other adverse events. Zyprexa was among the drugs studied. For their research, the … Continue reading

Posted in Pharmaceuticals |

EPA Proposes Stricter Rules over Formaldehyde Exposure

Formaldyhyde-Exposure

The U.S. Environmental Protection Agency (EPA) just proposed two rules to protect Americans from exposure to the harmful chemical, formaldehyde. The rules are consistent with a 2010 Federal law unanimously passed by Congress. The rules ensure that domestically produced or … Continue reading

Posted in Health Concerns, Legal News, Toxic Substances |

Wal-Mart Pleads Guilty to Federal Environmental Crimes, Civil Violations, to Pay More Than $81 Million

Walmart_Pleads_Guilty

Wal-Mart has admitted to violating criminal and civil laws meant to protect water quality and ensure proper handling of hazardous wastes and pesticides, the Environmental Protection Agency (EPA) announced. The retailer pleaded guilty to six counts of violating the Clean … Continue reading

Posted in Health Concerns, Legal News, Toxic Substances |

Experts Question Drugmakers’ Push to Treat Low Testosterone

Low-Testoterone

Drugmakers are lavishing millions of dollars on ads promoting the wonders of testosterone treatment, but they overhype the benefits and underplay the risks, according to Consumer Reports magazine. The print and television ads, primarily for two products, AndroGel and Axiron, … Continue reading

Posted in Health Concerns, Pharmaceuticals |

Study: Pesticide Exposure Increases Risks for Parkinson’s Disease

Pesticide_Exposure

For not the first time, a study suggests a link between Parkinson’s disease and pesticide exposure. Parkinson’s disease is a progressive, degenerative central nervous system disorder that typically affects motor skills and speech, among other functions and, while not fatal, … Continue reading

Posted in Health Concerns, Paraquat, PCBs, Perchlorate, Toxic Substances |

Yale’s Medtronic Reporting Expected Next Month

Yale_Medtronic_Reporting

As the fallout from a conflict-of-interest scandal continues, drug maker Medtronic, announced in its fiscal fourth-quarter earnings report that the results from a long-awaited Yale review are expected to be published next month. Medtronic has been the focus of a … Continue reading

Posted in Defective Medical Devices, Medtonic Infuse, Medtronic Infuse |

© 2005-2018 Parker Waichman LLP ®. All Rights Reserved.